Newsroom

PHILADELPHIA--(BUSINESS WIRE)--Crane Harbor Acquisition Corp. (NASDAQ:CHACU) (the "Company") has announced today the pricing of its initial public offering, which will consist of 20,000,000 units priced at $10.00 each. The units will be listed on the Nasdaq Global Market under the symbol "CHACU" and are set to start trading on April 25, 2025. Each unit offered includes one Class A ordinary share of the Company as well as a right to obtain one tenth (1/10) of a Class A ordinary share following t...

LONDRA--(BUSINESS WIRE)--La Global Cement and Concrete Association (GCCA) ha annunciato il lancio del Low Carbon Ratings (LCR) for Cement and Concrete, un sistema di classificazione globale trasparente unico nel suo genere che consentirà l'identificazione di cemento e calcestruzzo sulla base delle loro impronte di carbonio. Il sistema di classificazione è stato sviluppato per aiutare i clienti a dare priorità alla sostenibilità al momento di selezionare i materiali edili, grazie a una scala chi...

PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – een toonaangevende internationale CDMO (contract development & manufacturing organization) die zich specialiseert in innovatieve biofarmatherapieën – neemt een volledig aandelenbelang in Ajinomoto Althea, Inc. (“Althea”), een in de VS gevestigde CDMO die instaat voor steriele fill-finish en voor 100% dochteronderneming van het in Japan gevestigde Ajinomoto Co., Inc. Dankzij deze overname, die volgens planning in mei 2025 wordt vol...

NEW YORK & TOKYO--(BUSINESS WIRE)--Today, Nihon Global Growth Partners Management Inc. (“NHGGP”) announced that it has nominated, via an affiliated fund, two qualified outside directors for election to the Board of Toyo Suisan Kaisha Ltd. (2875.T) (“Toyo Suisan” or the “Company”) at the upcoming Annual General Meeting. The investor group led by NHGGP collectively owns approximately 4% of Toyo Suisan’s common shares. NHGGP also issued a presentation detailing the case for change at the Board lev...

HOUSTON--(BUSINESS WIRE)--The Port Commission of the Port of Houston Authority will hold its Regular Monthly Meeting on Tuesday, April 29, 2025, beginning at 9:15 a.m. in the boardroom of the Port Houston Executive Office Building, located at 111 East Loop North, Houston, TX 77029. It will be conducted as a hybrid meeting and open to the public to attend in person or accessed virtually via WebEx webinar. The agenda and instructions for accessing Port Houston public meetings are available at htt...

FILADELFIA--(BUSINESS WIRE)--PCI Pharma Services ("PCI"), un'organizzazione di sviluppo e produzione a contratto (CDMO) leader a livello mondiale e orientata alle terapie biofarmaceutiche innovative, sta acquisendo un'intera quota azionaria di Ajinomoto Althea, Inc. ("Althea"), un CDMO di riempimento e finitura sterili con sede negli Stati Uniti e controllata dell'azienda giapponese Ajinomoto Co., Inc. L'acquisizione, il cui completamento è previsto per maggio 2025, offre a PCI la prima sede di...

LONDON--(BUSINESS WIRE)--A Global Cement and Concrete Association (Globális Cement- és Betonszövetség, GCCA) bejelenti a Low Carbon Ratings (Alacsony szén-dioxid-besorolás, LCR) - a maga nemében elsőként átlátható globális minősítési rendszer bevezetését, amely lehetővé teszi a cement és a beton szénlábnyom alapján történő azonosítását. A minősítési rendszer célja, hogy egy érthető és intuitív AA-tól G-ig terjedő skála használatával segítse az ügyfeleket a fenntarthatóság előtérbe helyezésében...

FILADÉLFIA--(BUSINESS WIRE)--A PCI Pharma Services (“PCI”) – uma das principais organizações globais de desenvolvimento e fabricação de contratos (CDMO) com foco em terapias biofarmacêuticas inovadoras – está adquirindo uma participação acionária total na Ajinomoto Althea, Inc. (“Althea”), uma CDMO de enchimento e acabamento estéril com sede nos EUA e 100% subsidiária da Ajinomoto Co., Inc. Com conclusão prevista para maio de 2025, a aquisição fornece à PCI seu primeiro local de fabricação na A...

PHILADELPHIE--(BUSINESS WIRE)--PCI Pharma Services (« PCI »), une organisation mondiale de développement et de fabrication sous contrat (CDMO) de premier plan axée sur les thérapies biopharmaceutiques innovantes, acquiert une participation totale dans Ajinomoto Althea, Inc. (« Althea »), une CDMO de finition stérile basée aux États-Unis et filiale à 100 % de la société japonaise Ajinomoto Co., Inc. Cette acquisition, qui devrait être complétée en mai 2025, procure à PCI son tout premier site no...

FILADELFIA--(BUSINESS WIRE)--PCI Pharma Services («PCI»), una organización de desarrollo y fabricación por contrato (CDMO, por sus siglas en inglés) líder mundial centrada en terapias biofarmacéuticas innovadoras, está adquiriendo una participación accionaria completa en Ajinomoto Althea, Inc. («Althea»), una CDMO de llenado y acabado estéril con sede en Estados Unidos y filial al 100% de Ajinomoto Co., Inc. con sede en Japón. La adquisición, cuya finalización está prevista para mayo de 2025, a...